Powerlifting Athlete Suspended for the Presence of Seven Prohibited Substances
The Canadian Centre for Ethics in Sport (CCES) announced today that Jonathan Stanley, a powerlifting athlete, received a three-year sanction for an anti-doping rule violation. The athlete’s urine sample, collected in competition on June 3, 2023, revealed the presence of trenbolone, oxandrolone, clostebol, nandrolone, drostanolone, and testosterone, six prohibited anabolic agents, as well as methylphenidate, a prohibited specified stimulant.
On August 12, 2023, the athlete signed an Early Admission and Acceptance of Sanction, thereby admitting to the violation and accepting the asserted period of ineligibility and all other consequences. As a result, the otherwise applicable four-year period of ineligibility was reduced by one year in accordance with Canadian Anti-Doping Program (CADP) rule 10.8.1. Because the athlete was provisionally suspended, the sanction terminates on July 24, 2026.
During the sanction period, the athlete is ineligible to participate in any capacity with any sport signatory to the CADP or the World Anti-Doping Code, including training with teammates.
In compliance with rule 8.4 of the CADP, the CCES’s file outcome summary can be found in the Canadian Sport Sanction Registry.
